The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.
The following is a summary of “Reducing time delays and enhancing reperfusion eligibility related to stroke suspicion by the ...
(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Racine County Eye on MSN2d
Stroke survivor’s rapid recovery showcases life-saving emergency care by local medical personnelAscension Wisconsin recently honored Racine paramedics and the Ascension All Saints Hospital Emergency Department for their ...
The Healthy @Reader's Digest on MSN4d
6 Signs of a Stroke You Might Be IgnoringStroke is the fifth-leading cause of death nationwide. Brain damage from strokes can be minimized if they are treated ...
A Gering teenager is on the road to recovery after a life-threatening ATV accident and subsequent stroke, thanks to the swift ...
For patients with acute ischemic stroke whose symptoms began 4.5 to 24 hours earlier, alteplase is associated with a higher percentage of patients achieving a score of 0 or 1 on the modified Rankin ...
A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback